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Transient receptor potential melastatin 7 (TRPM7) is a ubiq-
uitously expressed Mg2-permeable ion channel fused to a
C-terminal -kinase domain. Recently, aldosterone was shown
to increase intracellular Mg2 levels and alter inflammatory
signaling in TRPM7-expressing HEK293 cells. This study was
undertaken to assess whether these effects were related to
an aldosterone-mediated increase of TRPM7 current and/or
plasma membrane localization. Using HEK293 cells stably
expressing WT-TRPM7, we found that 18-h application of
aldosterone significantly increasedTRPM7current andTRPM7
plasma membrane protein expression by 48% and 34%, respec-
tively. The aldosterone-mediated increase of TRPM7 current was
inhibited by eplerenone, a mineralocorticoid receptor (MR)
blocker, andGSK-650394,an inhibitorof theserum-andglucocor-
ticoid-regulated kinase 1 (SGK1). SGK1 blockade also prevented
the aldosterone-induced increase of TRPM7 plasma membrane
protein. Itwas furtherdetermined thatK1648R-TRPM7, thephos-
photransferase-inactive TRPM7 mutant, was unresponsive to
aldosterone. Therefore, chronic aldosterone treatment increases
the plasma membrane expression of TRPM7, which is associated
with an increase of TRPM7 current. This process occurs via an
MR-dependent, genomic signaling cascade involving SGK1 and a
functioningTRPM7-kinase domain.We suggest that thismech-
anismmay be of general relevancewhen interpreting the effects of
aldosterone because the MR receptor is found in multiple tissues,
and TRPM7 and SGK1 are ubiquitously expressed.
Aldosterone is a steroid hormone that regulates blood pres-
sure by enhancing Na reabsorption (1) in the distal convo-
luted tubule (2), connecting tubule (3), and collecting duct (4, 5)
of the nephron. These effects, as well as the homeostatic main-
tenance of Mg2 and K (6, 7), are mediated by both genomic
and non-genomic mechanisms. In the genomic cascade, aldos-
terone, through high-affinity interaction with themineralocor-
ticoid receptor (MR),3 increases the genomic expression of pro-
teins associated with electrolyte regulation (8, 9). The best
characterized protein, the epithelial Na channel (ENaC), is
enhanced through increased mRNA synthesis (10, 11) and
heightened biophysical function (12), leading to increased Na
reabsorption from the urinary filtrate (11). Aldosterone also
modulates ENaC through increased expression of the serum-
and glucocorticoid-regulated kinase 1 (SGK1) (13, 14), which
primarily enhances the plasmamembrane expression of ENaC,
leading to increased function (15–20).
The non-genomic actions of aldosterone have been divided
into four pathways: MR-dependent (21), EGF receptor trans-
activated (22), G-protein coupled receptor-dependent (23), and
MR-independent (24, 25). Importantly, it has been shown that
non-genomic activation of PKC led to MR phosphorylation,
and this was critical for the long-term genomic response to
aldosterone (24). Thus, there may be cross-talk between the
non-genomic and genomic signaling cascades.
Hyperaldosteronism, identified by elevated serum aldoster-
one levels (26), results in excessive Na reabsorption (27), K
wasting (28), andMg2 wasting (6). In the kidney, the majority
of Mg2 reabsorption occurs in the thick ascending limb via
paracellular transport, a process dependent on claudins 16 and
19 (29, 30). However, in the distal convoluted tubule, Mg2
reabsorption occurs via transcellular pathways, implicating
Mg2-permeable ion channels (31, 32). Transient receptor
potential melastatin 7 (TRPM7), a ubiquitously expressed
Mg2-permeable ion channel fused to a C-terminal -kinase
domain (33–37), has been identified as an aldosterone-respon-
sive protein. It was reported that aldosterone, through non-
genomic and genomic signaling cascades, increased intracellu-
lar Mg2 levels and modulated inflammatory signaling via
TRPM7 (38). However, it remains unclear whether these effects
are associated with an actual change in TRPM7 function at the
plasma membrane.
Using a combination of electrophysiological and biochemical
techniques, we determined the effect of aldosterone on the
TRPM7 channel. Our data demonstrate for the first time that
aldosterone increasesTRPM7macroscopiccurrentandthat this is
associatedwithelevatedTRPM7proteinat theplasmamembrane.
Moreover, we show that this effect is mediated by the MR along
with SGK1 and requires a functional TRPM7 -kinase domain.
Because SGK1 and TRPM7 are ubiquitously expressed, this may
beamechanismofgeneral relevanceassociatedwith theactivation
of theMR by aldosterone in various tissues.
* This study was funded by grants from the Canadian Institute of Health
Research (CIHR, MOP57786) (to R. M. T. and A. S.). The authors declare that
they have no conflicts of interest with the contents of this article.
Author’s Choice—Final version free via Creative Commons CC-BY license.
1 Supported through a Canada Research Chair/Canadian Foundation for
Innovation award and British Heart Foundation Chair (29762).
2 Towhomcorrespondence should be addressed: Dept. of Physiology,McGill
University, Bellini Bldg., Rm. 165, 3649 Promenade Sir William Osler, Mon-
treal, QC H3G 0B1, Canada. Tel.: 514-398-2272; Fax: 514-398-3942; E-mail:
alvin.shrier@mcgill.ca.
3 Theabbreviationsusedare:MR,mineralocorticoid receptor; ENaC, epithelial
sodiumchannel; pF, picofarad; I-V, current-voltage;G-V, conductance-volt-
age; LJP, liquid junction potential; RIPA radioimmune precipitation assay;
ANOVA, analysis of variance.
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 291, NO. 38, pp. 20163–20172, September 16, 2016
Author’s Choice © 2016 by The American Society for Biochemistry and Molecular Biology, Inc. Published in the U.S.A.
crossmark
SEPTEMBER 16, 2016•VOLUME 291•NUMBER 38 JOURNAL OF BIOLOGICAL CHEMISTRY 20163
 at G
lasgow
 U
niversity Library on M
arch 15, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Results
Tetracycline Induction of WT-TRPM7—Whole-cell currents
were evoked using a 50-ms voltage ramp from 100 mV to
100 mV (Fig. 1A). 18-h application of 1 g/ml of tetracy-
cline to HEK293 cells stably expressing WT-hTRPM7 in
pcDNA4/TO (iWT-TRPM7) gave rise to a large macroscopic
current that was not present in non-transfected HEK293 cells
(Fig. 1, A and C). iWT-TRPM7 currents were outwardly recti-
fying-positive to 0 mV, reversed at 0 mV, and small and non-
rectifying-negative to 0 mV. In accordance with prior reports
(39, 40), iWT-TRPM7currentswere small after the initial patch
rupture but, within 30 s, began to progressively increase until a
peak was observed by 7–10 min (Fig. 1B). It can be seen in Fig.
1D that, compared with non-transfected HEK293 cells, cur-
rents were 1009% larger at 100 mV and 56% larger at 100
mV in iWT-TRPM7 cells.
Aldosterone Increases TRPM7 Current—TRPM7 has been
implicated in the aldosterone-mediated increase of intracellu-
lar Mg2 and altered inflammatory signaling (38). However,
there was no evidence provided to support a direct effect of
aldosterone on TRPM7 current. As shown in Fig. 2A, 18-h
treatment of aldosterone (100 nM concurrently with tetracy-
cline) increased the outward current limb of the iWT-TRPM7
I-V relationship so that a statistically significantly increase was
observed at100mV (243 9 pA/pF to 360 39 pA/pF) (Fig.
2B). This significant increase was due to an effect on recombi-
nant WT-TRPM7, as native HEK293 currents were not signif-
icantly increased by aldosterone treatment, although the mean
current density at 100 mV was slightly larger (22  3 pA/pF
versus 17  2 pA/pF, respectively) (Fig. 2, C and D). Further-
more, although there are reports of low-levels of TRPM7
expression in HEK293 cells (38), it is not entirely clear what
fraction of the endogenous macroscopic current TRPM7 con-
stitutes, as the HEK293 I-V relationship is not unique to
TRPM7 (41). Thus, it is uncertain what fraction of the HEK293
macroscopic current would be aldosterone-responsive.
To assess whether aldosterone could modulate TRPM7 cur-
rent through rapid, non-genomic pathways, iWT-TRPM7 cells
were assessed under acute aldosterone treatment. No changes
in peak current were observed when iWT-TRPM7 cells were
superfused with 100 nM aldosterone and recorded for 15–20
min (Fig. 2E). This duration was chosen in accordance with
prior studies examining non-genomic aldosterone signaling
(21–25, 42–47).
MRand SGK1Mediate the Effect of Aldosterone on TRPM7—
To test the involvement of theMR, we employed theMR antag-
onist eplerenone (48) at an IC50 concentration of 360 nM (49).
Fig. 3A shows that eplerenone diminished the aldosterone-in-
duced increase of iWT-TRPM7 current. At 100 mV, peak
currents were 206 6 pA/pF for iWT-TRPM7 cells, 330 34
pA/pF for aldosterone-treated iWT-TRPM7 cells, and 246 
34 pA/pF for aldosterone/eplerenone-treated iWT-TRPM7
cells (Fig. 3B). The difference between the peak outward cur-
rents of non-treated and aldosterone/eplerenone-treated iWT-
TRPM7 cells was not statistically significant, indicating that
MR blockade prevented the aldosterone-mediated increase in
TRPM7 current.
SGK1 is a secondary mediator of the aldosterone/MR
genomic signaling cascade (50) known to increase the expres-
sion (10, 11), surface accumulation (15, 51), and function (12) of
FIGURE 1. Tetracycline induction ofWT-hTRPM7 generates outwardly rectifying currents in HEK293 cells. A, 50-ms ramp depolarization from100mV
to100mV (top panel) was imposed to evoke TRPM7 current (bottompanel) in a non-transfectedHEK293 cell (red) and an iWT-TRPM7 cell (black). B, growth of
iWT-TRPM7 currents as a function of time followingwhole-cell configurationmeasured at100mV (blue) and100mV (red). Note that the current reaches a
plateau level at about 7–10min. C, I-V relationship obtained using the ramp protocol in non-transfected HEK293 cells (n 6, red) and iWT-TRPM7 cells (n 8,
black). D, comparison of the current magnitudes between HEK293 cells and iWT-TRPM7 cells at100 mV (top panel) and100 mV (bottom panel). Data are
expressed as mean S.E. in grouped analyses.
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ENaC, resulting in increased Na reabsorption in the distal
nephron (13).We tested whether SGK1 function was necessary
for the aldosterone effect observed in TRPM7-expressing
HEK293 cells using 6MGSK-650394, a compound that inhib-
its the enzymatic activity of SGK1 (52). Concurrent treatment
of iWT-TRPM7 cells with aldosterone and GSK-650394
resulted in an I-V relationship essentially identical in magni-
tude to non-treated iWT-TRPM7 cells (Fig. 3C). At100 mV,
iWT-TRPM7 current was 616  51 pA/pF for aldosterone-
treated cells, 404  52 pA/pF for aldosterone/GSK650394-
treated cells, and 345  51 pA/pF for non-treated cells (Fig.
3D). The difference in peak current between non-treated and
aldosterone/GSK-650394-treated iWT-TRPM7 cells was not
statistically significant, indicating that SGK1 blockade also pre-
vented the aldosterone-mediated increase in TRPM7 current.
A common mechanism by which SGK1 increases channel
activity is via increased plasma membrane expression, a result
observed for ENaC (15), renal outermedullary potassium chan-
nel 1 (ROMK1) (53), ClC-Ka (54), and transient receptor poten-
tial vanilloid 5 (TRPV5) (55). To assess whether SGK1
increased the plasma membrane expression of TRPM7, bioti-
nylation protocols were utilized. Fig. 4A shows a sample blot of
biotin pulldowns (left panel), indicative of plasma membrane
proteins, and whole-cell lysates (right panel), indicative of total
protein, for HEK293 cells expressing WT-hTRPM7. A single
band of 220 kDa, the expected size of TRPM7 (34), was
detected in the iWT-TRPM7 biotinylated pulldowns. A stron-
ger band of the same size was also detected in the iWT-TRPM7
lysates. To rule out potential plasmamembrane non-specificity
of the biotinylated products, we blotted for calreticulin, a pro-
tein localized to the endoplasmic reticulum (56). Fig. 4A further
shows that calreticulin was only present in the whole-cell
lysates and not in the pulldown products. When treated with
aldosterone, iWT-TRPM7 plasma membrane expression
increased by 34% (p  0.0291; Fig. 4, B and C), indicating that
aldosterone significantly increased plasmamembrane TRPM7.
This increase was prevented by co-application of GSK-650394
(Fig. 4, B and C), supporting the patch clamp data above.
Changes in iWT-TRPM7 whole-cell lysate levels (normalized
to -tubulin) were also observed with aldosterone application
FIGURE 2. Aldosterone treatment increases TRPM7 current. A, I-V relationship of non-treated (n  8, red) and 18-h aldosterone-treated (n  8, blue)
iWT-TRPM7 cells. B, current magnitude for the groups in Ameasured at100 mV. C, I-V relationship of non-treated (n 6, red) and 18-h aldosterone-treated
(n8,blue) nativeHEK293 cells.D, currentmagnitude for thegroups inCmeasuredat100mV. E, currentmagnitudeof iWT-TRPM7cells before (red) andafter
(blue) aldosterone superfusion for 15–20min (n 6)measured at100mV. Statistical comparisonswere performed using unpaired, two-way Student’s t test.
All data are expressed as mean S.E. Data were considered significant when p 0.05.
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(increase of 21%); however, these results were not statistically
significant (Fig. 4, D and E).
Aldosterone Does Not Change TRPM7Voltage Dependence of
Activation—G-V relationships for non-treated and aldoster-
one-treated iWT-TRPM7 cells are shown in Fig. 5A and nor-
malized in Fig. 5B. The two normalized G-V relationships in
Fig. 5B were fit with the Boltzmann function. The V50 values
(the voltage at which the G/Gmax is 0.5) (86  2 mV for non-
treated and 83 2 mV for aldosterone-treated) and slopes (16
for non-treated and 16 for aldosterone-treated) were highly
similar, indicating that the increase of TRPM7 current attrib-
uted to aldosterone treatment was not associated with changes
in TRPM7 voltage dependence of activation.
Aldosterone Requires a Functional TRPM7-Kinase Domain
to Enhance TRPM7 Current—To determine whether the
TRPM7 -kinase was required for the aldosterone-induced
increase of TRPM7 plasma membrane expression and
whole-cell current, we studied HEK293 cells stably express-
ing a TRPM7 -kinase phosphotransferase-inactive mutant,
K1648R-TRPM7. When treated with aldosterone, no signifi-
cant changes in induced K1648R-TRPM7 (iK1648R-TRPM7)
currents (Fig. 6,A and B), plasmamembrane expression (Fig. 6,
C andD), or total protein (Fig. 6, E and F) were observed. Thus,
a functional TRPM7 -kinase is necessary for aldosterone to
increase TRPM7 plasma membrane expression and macro-
scopic current.
Discussion
In this study, we demonstrate that aldosterone increases the
plasma membrane expression of TRPM7. This effect is medi-
ated by the MR and is SGK1-dependent. Furthermore, a func-
tional TRPM7 -kinase is required for the aldosterone-stimu-
lated increase of TRPM7 plasma membrane expression and
macroscopic current.
The results of this study support the notion that aldosterone
signaling via TRPM7 is mediated through genomic and kinase-
dependent mechanisms (38). Moreover, our results suggest
that these previously observed effects were associated with
changes in TRPM7 plasma membrane expression and whole-
cell current, indicating that the effect of aldosterone involves
functional TRPM7 channels. However, our results also suggest
that the previously observed acute increase of intracellular
Mg2 in aldosterone-treated iWT-TRPM7 cells was not caused
by increased Mg2 transport via TRPM7, as there were no
acute aldosterone-induced increases of iWT-TRPM7 macro-
scopic current. It is possible that the increased intracellular
Mg2 observed in the earlier study was due to the activation of
another Mg2 transporter, such as the ubiquitously expressed
magnesium transporter 1 (MagT1) (57, 58), which was identi-
fied as an important protein in Mg2 uptake (58, 59).
The results of this study also implicate SGK1, which is
expressed in virtually all tissues (60) and has been shown to be
genomically upregulated by aldosterone (61). SGK1, in turn,
regulates a variety of ion channels (15, 53–55, 62–65). The
most common mechanism by which SGK1 regulates ion chan-
nels is through increased ion channel plasma membrane abun-
dance, a process documented for the renal ion channels ENaC
(15), ROMK1 (53, 62), ClC-Ka (54), and TRPV5 (55). In this
study, we found that aldosterone induced similar increases in
FIGURE 3. Aldosterone induces TRPM7 macroscopic current via the MR and SGK1. A, I-V relationship of iWT-TRPM7 cells treated with (n  8, black) or
without (n  8, red) eplerenone as well as iTRPM7 cells treated with aldosterone (n  6, blue) or with aldosterone  eplerenone (n  7, green). B, current
magnitude for the groups examined in Ameasured at100mV. C, I-V relationship comparing non-treated (n 11, red), aldosterone-treated (n 8, blue), and
aldosteroneGSK-650394 (n 10,green) iWT-TRPM7cells.D, currentmagnitude for thegroups compared inCmeasured at100mV. Statistical comparisons
were performed using one-way ANOVAwith Bonferroni post-hoc tests. All data are expressed asmean S.E. Data were considered significant when p 0.05.
*, p 0.05; **, p 0.01.
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FIGURE 4. Aldosterone increases WT-TRPM7 plasma membrane protein expression. A, representative Western blot showing TRPM7 biotinylated (left
panel) and total lysate (right panel) samples. Calreticulin is presented as a control for biotinylation plasma membrane specificity. -Tubulin is presented as a
loading control.B,Westernblot showingplasmamembraneexpressionof TRPM7 innon-treated, aldosterone-treated, andaldosteroneGSK-650394-treated
iWT-TRPM7 cells. C, quantification (n 4) of plasma membrane expression. Aldo, aldosterone. D, Western blot showing TRPM7 lysate levels in non-treated,
aldosterone-treated, and aldosteroneGSK-650394-treated iWT-TRPM7 cells. E, quantification (n 4) of protein lysate levels. Lysate datawere normalized to
-tubulin. Statistical comparisons were performed using Kruskal-Wallis with Dunn’s post-hoc tests. Data are expressed as mean S.E. in grouped analyses.
Data were considered significant when p 0.05. **, p 0.01.
FIGURE 5.TRPM7voltagedependenceof activation is not changedbyaldosterone.A, G-V relationship of non-treated (n 7, red) and aldosterone-treated
(n 8, blue) iWT-TRPM7 cells. B, normalized conductance (G/Gmax)-voltage relationship of A fitted to the Boltzmann equation. Data are expressed as mean
S.E. for the I-V plot and mean S.D. for the Boltzmann function.
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TRPM7 current (48%) and TRPM7 plasma membrane expres-
sion (34%). The difference between these values is most likely
attributable to the semiquantitative nature of the biotinylation
assay. Moreover, the voltage dependence of TRPM7 activation
did not change in response to aldosterone treatment. There-
fore, we suggest that SGK1 increases TRPM7 plasma mem-
brane expression, resulting in increases inTRPM7macroscopic
current.
The role of the TRPM7 -kinase in channel function has
been assessed previously. Point mutations within the TRPM7
-kinase do not affect TRPM7 current magnitude but alter the
inhibitory capacity of Mg2 nucleotides (66). With regards to
aldosterone, our primary conclusion based on the kinase-mu-
tant data is that a loss of phosphotransferase activity abolishes
the aldosterone response, suggesting that SGK1 regulation of
TRPM7 occurs via the -kinase.
The mechanisms behind Mg2 wasting in hyperaldosteron-
ism remain uncertain. The results of this study demonstrate
that aldosterone increases the plasma membrane expression of
TRPM7, resulting in increased macroscopic current. However,
Mg2 wasting is difficult to assess in an isolated context, as 14
Mg2 channels or transporters have been identified in renal
distal convoluted tubular cells (32, 57, 67–74), where aldoster-
one would have a biological function (3, 75).
The relationship between aldosterone, SGK1, and TRPM7 is
of general significance, as SGK1 (60) and TRPM7 (33) are ubiq-
uitously expressed. Therefore, TRPM7 may be upregulated in
any cell stimulated by aldosterone. For example, in the acidic
distal tubule, where aldosterone and SGK1 have been impli-
cated previously (15, 53–55, 62), apically locatedTRPM7would
function as an Na channel (40), increasing intracellular Na
transport and, therefore, Na reabsorption. However, in vascu-
FIGURE 6.Aldosterone-stimulated increase of TRPM7macroscopic current and plasmamembrane expression requires a functional TRPM7-kinase.
A, I-V relationship of non-treated iWT-TRPM7 cells (n 8, purple), non-inducedK1648R-TRPM7 cells (n 6, black), non-treated iK1648R-TRPM7 cells (n 9, red),
and aldosterone-treated (n 10, blue) iK1648R-TRPM7 cells. B, comparison of current magnitude between the groups in Ameasured at100mV. C, Western
blot showing plasma membrane expression of TRPM7 in non-treated and aldosterone-treated iK1648R-TRPM7 cells. D, quantification (n  5) of plasma
membrane expression. E, Western blot showing lysate levels of non-treated and aldosterone-treated iK1648R-TRPM7 cells. F, quantification (n 5) of protein
lysate levels. Lysate data were normalized to -tubulin. Patch clamp data were statistically compared using unpaired, two-way Student’s t-tests. Western
blotting datawere statistically compared by one-sampleWilcoxon signed-rank test. Data are expressed asmean S.E. Datawere considered significantwhen
p 0.05.
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lar cells, which synthesize aldosterone (76) and also express the
required aldosterone genomic signaling moieties (77–79),
TRPM7would function as a divalent cation channel, increasing
the intracellular transport of Mg2 and Ca2 and participating
in the inflammatory cascade (38). Thus, there may be different
functional consequences of TRPM7 upregulation by aldoster-
one. Furthermore, the potential widespread nature of the aldos-
terone/TRPM7 response should be considered in future studies
investigating aldosterone pathologies.
Experimental Procedures
Tissue Culture and TRPM7 Induction—HEK293 cells were
grown in DMEM (low-glucose, Gibco) supplemented with 10%
FBS (Wisent Bioproducts), 100 units/ml penicillin, and 100
g/ml streptomycin (Gibco). 400 g/ml zeocin (Invitrogen)
and 5 g/ml blasticidin (Invitrogen) were further added to
maintain stable expression of TRPM7 constructs. Cells were
cultured at 37 °C in 5% CO2. Cell medium was changed every
3–4 days, and cells were passaged every 4–5 days via
trypsinization.
HEK293 cells were stably transfected with HA-tagged WT
hTRPM7 or phosphotransferase-inactive K1648R hTRPM7 in
pcDNA4/TO vectors (38, 66). This expression system has been
used in prior electrophysiological studies of TRPM7 (33, 35, 40,
80). TRPM7 expression was induced by the addition of 1g/ml
tetracycline (Sigma) 18 h prior to experimentation, as described
previously (38, 66). In experiments examining aldosterone, cells
were concurrently induced with tetracycline (18 h) and treated
(18 h) with 100 nM aldosterone (Sigma) (0.004% ethanol vehi-
cle) unless indicated otherwise. In experiments utilizing antag-
onists, cells were also treated (18 h) with 360 nM eplerenone
(0.1% DMSO vehicle) (Tocris) or 6 M GSK-650394 (0.1%
DMSO vehicle) (Tocris). Cell induction and treatments were
performed on 60–90% confluent HEK293 cells grown in 60- or
100 mm-diameter Petri dishes.
Electrophysiology—Cells were plated in the perfusion cham-
ber of an inverted microscope (Zeiss Axiovert S100TV) and
perfused at a rate of 1–2ml/min with Tyrode solution (145mM
NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, and 5 mM
HEPES (pH to 7.4 with NaOH, 285 mosmol)). Patch pipettes
were fabricated using borosilicate glass capillaries (Warner
Instruments, Hamden, CT) and a microprocessor-controlled,
multistage micropipette puller (P97, Sutter Instruments).
Pipettes with resistances of 1.5–3 megohms were backfilled
with pipette solution (130 mM CsCl, 10 mM NaCl, 10 mM
Cs41,2-bis(o-aminophenoxy)ethane-N,N,N,N-tetraacetic
acid, and 10 mM HEPES (pH to 7.2 with CsOH, 285 mosmol)).
Patch clamp experimentswere performed at room temperature
(21 °C).
Cells were recorded in the whole-cell configuration, as per-
forated patch is not optimal for TRPM7 current growth (81).
Whole-cell experiments were conducted using an Axopatch
200B amplifier coupled with a CV 203BU headstage. Data were
obtained using pClamp 10.4 and a Digidata 1440A digitizer
(Axon Instruments). Data were sampled at 20 kHz and filtered
at 2 kHz. To limit cellular toxicity and variation in tetracycline-
induced currents, cells were recorded 18–24 h after induction
(35). n refers to the number of cells recorded, each from a sep-
arate dish. The total n for each experimental condition was
generated from a minimum of three separate inductions.
Prior to the formation of a gigaohm seal, currents were cor-
rected for pipette (fast) capacitance. Upon formation of the
whole cell-configuration, cell capacitance was determined
using a 30-ms, 10-mVdepolarizing pulse from a holding poten-
tial of80 mV at 2 Hz. Currents were corrected for whole-cell
capacitance and series resistance compensated to 80%. All
recorded cells had access resistances below 10 megohms.
The liquid junction potential (LJP) between the Tyrode solu-
tion and the pipette solution (2 mV) was compensated offline
using the formula Vmembrane  VPipette  VLJP (82). I-V rela-
tionships were obtained using a 50-ms ramp protocol from
100 to100mV, from a holding potential of 0 mV, at 0.5 Hz.
The protocol was applied for 700 s and repeated when
necessary.
Currents in the I-V relationships are presented as current
density (picoampere/picofarad), where picofarad was deter-
mined by cellular capacitance. Where appropriate, G-V rela-
tionships are presented. Conductance was calculated by divid-
ing the recorded current (picoampere) by the driving force
(VdrivingVtestVreversal). To fit G-V relationships to a Boltz-
mann function, plots were normalized to peak conductance
and are presented as G/Gmax. In cells expressing TRPM7, cur-
rentmagnitude increased over time following patch rupture for
7–10 min until a maximum current was observed (Fig. 1B).
I-V relationships are presented as maximal currents.
Biotinylation—Upon removal from the incubator, cells were
maintained at 4 °C and washed on ice with ice-cold PBS (140
mM NaCl, 3 mM KCl, 10 mM Na2HPO4, and 2 mM KH2PO4)
containing 1 mMMgCl2 and 0.1 mM CaCl2 (pH 8.0) (PBS-CM).
Cells were incubated with 0.5 mg/ml EZ-LinkTM sulfo-NHS-
SS-biotin (Thermo Scientific) in PBS-CM for 30 min on ice.
Cells were washed and then incubated with quenching buffer
(50 mM glycine in PBS-CM) for 7 min on ice. This step was
repeated a second time. Cells werewashed twomore timeswith
PBS-CMand then harvested and lysed in radioimmunoprecipi-
tation assay buffer (150 mM NaCl, 20 mM Tris-HCl (pH 8), 1%
Triton X-100, 0.1% SDS, and 0.5% sodium deoxycholate). A
small fraction of the cell lysates was removed for use inWestern
(lysate) blotting, and the remainder was incubated with 100 l
of 50% Neutr-Avidin-agarose slurry (Thermo Scientific) in
RIPA buffer with a protease inhibitor mixture (Roche Applied
Science) overnight at 4 °C. The biotinylated protein complexes
were washed four times in RIPA buffer and eluted with 2	
Laemmli loading buffer (100 mM Tris-HCl (pH 6.8), 10% glyc-
erol, 10% SDS, and 10%-mercaptoethanol) for 45min at room
temperature. Samples were then used in Western blotting.
Western Blotting—Samples were loaded and separated by 6%
SDS-polyacrylamide gel electrophoresis, and protein bands
were subsequently transferred onto nitrocellulose membranes
(Bio-Rad). Membranes were blocked with a 5% milk solution
and then incubated overnight with antibodies at 4 °C. Immuno-
blots were incubated with secondary antibodies and visualized
using Amersham Biosciences ECL Western blotting detection
reagent (GEHealthcare Life Sciences). -Tubulin was used as a
loading control. After observing no intracellular calreticulin
or -tubulin with biotinylation (elution) blots (Fig. 4A), all
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subsequent elution blots are depicted without controls, as
presented previously (83). Antibodies used were as follows:
anti-TRPM7 (NeuroMab, clone N74/25, monoclonal), anti-
-tubulin (Sigma, monoclonal), anti-calreticulin (Stressgen,
polyclonal), peroxidase-conjugated AffiniPure goat anti-
rabbit (Jackson ImmunoResearch Laboratories, polyclonal),
and peroxidase-conjugated AffiniPure goat anti-mouse
(Jackson ImmunoResearch Laboratories, polyclonal).
Statistical Analysis—All statistical analyses were performed
in GraphPad Prism 5.0. Data are expressed as mean  S.E.
unless indicated otherwise. Data from the Boltzmann function
are presented as mean S.D. To evaluate significance between
two groups, unpaired, two-way Student’s t tests were used
unless otherwise indicated. To evaluate statistical significance
between three groups, one-way ANOVAwith Bonferroni post-
hoc tests were used. To evaluate statistical significance for nor-
malized protein quantification between two groups, a one-sam-
ple Wilcoxon signed-rank test was used. To evaluate statistical
significance for normalized protein quantification between
three groups, Kruskal-Wallis with Dunn’s post-hoc tests were
used. In accordance with prior studies studying aldosterone
(21, 84–88) and SGK1 (89), whole-cell lysates data were nor-
malized to -tubulin. Furthermore, in this study, -tubulin lev-
els were unaffected by aldosterone treatment, as relative to con-
trol, -tubulin quantification was 0.88 for aldosterone and 0.89
for aldosterone  GSK-650394 in iWT-TRPM7 cells. Data
were considered significant when p 0.05. Precise p values are
depicted for ANOVA, Kruskal-Wallis test, t test, and rank test
results. In post-hoc tests, statistical significance is indicated as
follows: *, p 0.05; **, p 0.01; ***, p 0.001; ****, p 0.0001.
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